Home
Arrakis Therapeutics

Arrakis Therapeutics Market Share Analysis for August 2026

September 6, 2022 BioPharma Dive Drugging RNA with pills: small molecules for a big frontier April 8, 2022 Chemical & Engineering News Jennifer Petter Wants to Interfere with RNA to Discover New Drug Targets January 13, 2022 STAT The Readout Loud Podcast #JPM22 in review, Biogen’s worsening fortunes, & the future of RNA drugs Michael […]

Health > Biotechnology and Pharmaceuticals

Domainarrakistx.com

Year Founded2015

Employees51 - 200

Annual Revenue$2M - $5M

Arrakis Therapeutics

Arrakis Therapeutics (including company regionals)

arrakistx.com

See more website traffic and engagement information

Arrakis Therapeutics Revenue up to August 2026 is 2M - 5M

revenue generated by Arrakis Therapeutics top domains

Arrakis Therapeutics top domains revenue over 3 years

Revenue for Arrakis Therapeutics top domains

arrakistx.com2M - 5M

See more with Sales Intelligence

Total visits to Arrakis Therapeutics's top domains

Understand Arrakis Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

arrakistx.com4.1K

See more with Sales Intelligence

Avg. visit duration in Arrakis Therapeutics's top domains

Analyze Arrakis Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

arrakistx.com00:00:39

See more with Sales Intelligence

Avg. pageviews on Arrakis Therapeutics's top domains

See how Arrakis Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

arrakistx.com1.83

See more with Sales Intelligence

Arrakis Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Arrakis Therapeutics

These are the website technologies, by industry, used by Arrakis Therapeutics top domains

Social (5)

Instagram

Content Management System (4)

WordPress

Widget (4)

Twemoji

Advertising (2)

DoubleClick

More Technologies

6

See all

News & Signals from Arrakis Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsArrakistx is developing oral genetic medicines that directly target disease-causing RNA on Jun 25th '26.Based in Waltham, Massachusetts, Arrakis Therapeutics is developing oral genetic medicines that directly target disease-causing RNA.

NewsArrakistx promoted Katrine Bosley on Jun 25th '26.The CEO transition follows the retirement of Michael Gilman, PhD. Dr. Gilman will continue to serve on the Arrakis Board of Directors and become Chairman, as Katrine Bosley, who has chaired the Board for seven years, transitions that role to him and steps down from the company's Board.